Moreover, COX-2 also participates in the immunomodulation of the tumor microenvironment by promoting the M2 phenotype of macrophages, inhibiting antigen-presenting cells and reducing CD8+ T cells, all of which impair the antitumoral immune response (235). The gene discussed is PTGS2; the disease is neoplasm.